NECSYLLDI Trademark

Trademark Overview


On Monday, May 6, 2024, a trademark application was filed for NECSYLLDI with the United States Patent and Trademark Office. The USPTO has given the NECSYLLDI trademark a serial number of 79398424. The federal status of this trademark filing is REGISTERED as of Tuesday, February 18, 2025. This trademark is owned by Boehringer Ingelheim International GmbH. The NECSYLLDI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention ...
necsylldi

General Information


Serial Number79398424
Word MarkNECSYLLDI
Filing DateMonday, May 6, 2024
Status700 - REGISTERED
Status DateTuesday, February 18, 2025
Registration Number7691574
Registration DateTuesday, February 18, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 31, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; pharmaceutical preparations, namely, cell based immune therapeutics for treatment of cancer, for treatment of immunological diseases, and treatment of infectious diseases.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 23, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE

Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE

Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events


Event DateEvent Description
Thursday, June 27, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, July 23, 2024LIMITATION FROM ORIGINAL APPLICATION ENTERED
Wednesday, July 24, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 24, 2024APPLICATION FILING RECEIPT MAILED
Tuesday, November 19, 2024ASSIGNED TO EXAMINER
Wednesday, November 20, 2024NON-FINAL ACTION WRITTEN
Thursday, November 21, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, December 5, 2024REFUSAL PROCESSED BY MPU
Thursday, December 5, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, December 9, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 9, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 10, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 10, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, December 21, 2024REFUSAL PROCESSED BY IB
Wednesday, December 25, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 31, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 31, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 18, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, February 18, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Monday, May 19, 2025FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, September 2, 2025FINAL DISPOSITION PROCESSED
Tuesday, September 2, 2025FINAL DISPOSITION NOTICE SENT TO IB
Friday, September 19, 2025FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, November 26, 2025NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, November 26, 2025NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, December 11, 2025NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB